analyzing real-world data for car t-cell therapy in patients with all and dlbcl
Published 4 years ago • 235 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:30
dr. lekakis on real-world data with car t-cell therapy in lymphoma
-
5:55
car t-cell therapy in dlbcl
-
3:05
real-world data on axi-cel for patients with large b-cell lymphoma
-
1:17
real-world data for axi-cel in broader dlbcl population
-
8:33
cd19-targeted car t-cell therapy in managing dlbcl
-
10:57
car-t for lymphoma: new targets, real world data & resistance
-
3:05
real-world efficacy & safety data: car-t in dlbcl
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
1:38
car t-cell therapy appears promising in relapsed/refractory dlbcl
-
3:42
an overview of car-t therapy in dlbcl and mcl
-
45:46
cd19 targeted car t-cell therapy in lbcl
-
56:44
treatment innovation in dlbcl: real-world insight on integrating antibodies and cellular therapy
-
2:52
current immunotherapeutic approaches in dlbcl: the value of car-t cells and bispecific antibodies
-
15:50
biomarkers and patient eligibility for car t-cell therapies in dlbcl
-
58:56
car-t cell therapy for leukemia and lymphoma: exploring modern cellular therapies
-
4:28
selecting dlbcl patients for car t-cell therapies
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
6:55
potential for car t-cell therapy in b-cell lymphomas